Agency reports 5,542 enforcement operations, advances local drug production and pursues WHO Level 4 regulatory status.
By Bunmi Yekini
Nigeria’s food and drug regulator, NAFDAC, destroyed unwholesome products valued at about ₦22.73 billion between January and August 2026 as part of efforts to curb the circulation of substandard and falsified products.
The National Agency for Food and Drug Administration and Control (NAFDAC) said it conducted 22 destruction exercises during the period, alongside 5,542 enforcement activities targeting illegal and unsafe products.
The enforcement operations also resulted in 213 raids, 821 product seizures, the closure of 179 premises, 52 arrests and 221 sanctions, the agency said.
NAFDAC disclosed the figures during a regulatory update presentation at the International Pharmaceutical Regulators Programme (IPRP) Management Committee Meeting held in Prague, Czech Republic, from November 18 to 19.
The agency also reported progress in strengthening Nigeria’s pharmaceutical regulatory system, including maintaining its World Health Organisation (WHO) Maturity Level 3 status while working towards Level 4, the highest level under the WHO Global Benchmarking Tool.
It said several digital initiatives were supporting the transition, including the Integrated Regulatory Information Management System (IRIMS), Performance Management System (i-PMS), Good Manufacturing Practice (GMP) Inspection system and AI-assisted Technical Screening Tools.
The agency also highlighted its revised Med Safety App, designed to strengthen the reporting of substandard and falsified medical products as well as adverse drug reactions.
On local pharmaceutical manufacturing, NAFDAC said more than 70 per cent of finished pharmaceutical products covered by its 5+5 Policy and Ceiling 36 initiative were now being manufactured locally.
The policy is intended to reduce Nigeria’s dependence on imported medicines and strengthen domestic production capacity and medicine security.
The regulator also reported expanding its role in Africa, saying it had hosted regulatory authorities from Uganda, The Gambia, Mozambique and Côte d’Ivoire for technical capacity building and institutional benchmarking.
Nigeria further ratified the African Medicines Agency (AMA) Treaty and deposited its instruments of ratification on October 25, 2026, the agency said.
The developments form part of a broader effort by NAFDAC, under its Director-General, Professor Mojisola Christianah Adeyeye, to strengthen regulatory oversight, improve public health protection and expand Nigeria’s influence in pharmaceutical regulation across Africa.
NAFDAC said it would continue to invest in regulatory capacity, digital innovation, local pharmaceutical manufacturing and international cooperation.
